Rank | Gene Set | Z-score |
---|---|---|
1 | sodium ion export (GO:0071436) | 4.60233513 |
2 | lysine metabolic process (GO:0006553) | 4.37292118 |
3 | lysine catabolic process (GO:0006554) | 4.37292118 |
4 | regulation of cholesterol homeostasis (GO:2000188) | 4.15190501 |
5 | alpha-linolenic acid metabolic process (GO:0036109) | 3.86460082 |
6 | negative regulation of cell size (GO:0045792) | 3.76903963 |
7 | basement membrane organization (GO:0071711) | 3.72143732 |
8 | barbed-end actin filament capping (GO:0051016) | 3.61146945 |
9 | regulation of early endosome to late endosome transport (GO:2000641) | 3.52110573 |
10 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.51172914 |
11 | adherens junction assembly (GO:0034333) | 3.45726658 |
12 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.42289968 |
13 | cysteine metabolic process (GO:0006534) | 3.42176095 |
14 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.36971967 |
15 | cell-substrate adherens junction assembly (GO:0007045) | 3.31305388 |
16 | focal adhesion assembly (GO:0048041) | 3.31305388 |
17 | aspartate family amino acid catabolic process (GO:0009068) | 3.31250979 |
18 | sulfur amino acid catabolic process (GO:0000098) | 3.28243116 |
19 | 2-oxoglutarate metabolic process (GO:0006103) | 3.27650718 |
20 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.26682628 |
21 | tricarboxylic acid metabolic process (GO:0072350) | 3.25852422 |
22 | cell-substrate junction assembly (GO:0007044) | 3.20498501 |
23 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.20078996 |
24 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.18898949 |
25 | skin morphogenesis (GO:0043589) | 3.16200110 |
26 | cellular potassium ion homeostasis (GO:0030007) | 3.12820683 |
27 | phosphate ion transport (GO:0006817) | 3.12048739 |
28 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.11625496 |
29 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.10209823 |
30 | phosphate ion transmembrane transport (GO:0035435) | 3.10089695 |
31 | semaphorin-plexin signaling pathway (GO:0071526) | 3.10077740 |
32 | cell communication by electrical coupling (GO:0010644) | 3.09738678 |
33 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.06694817 |
34 | COPI coating of Golgi vesicle (GO:0048205) | 3.06643573 |
35 | Golgi transport vesicle coating (GO:0048200) | 3.06643573 |
36 | sexual reproduction (GO:0019953) | 3.05702149 |
37 | synaptic vesicle maturation (GO:0016188) | 3.04668682 |
38 | activation of Rac GTPase activity (GO:0032863) | 3.01792669 |
39 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.00785688 |
40 | low-density lipoprotein particle clearance (GO:0034383) | 2.99108392 |
41 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.97104133 |
42 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.96635923 |
43 | hemidesmosome assembly (GO:0031581) | 2.95724793 |
44 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.93635257 |
45 | apoptotic cell clearance (GO:0043277) | 2.91956319 |
46 | cellular modified amino acid catabolic process (GO:0042219) | 2.91894429 |
47 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.88970852 |
48 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.88649521 |
49 | apoptotic process involved in morphogenesis (GO:0060561) | 2.88403862 |
50 | glucose 6-phosphate metabolic process (GO:0051156) | 2.88175857 |
51 | pentose-phosphate shunt (GO:0006098) | 2.86544657 |
52 | protein maturation by protein folding (GO:0022417) | 2.86330632 |
53 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.86219382 |
54 | macroautophagy (GO:0016236) | 2.85997436 |
55 | regulation of cholesterol storage (GO:0010885) | 2.85416368 |
56 | regulation of fatty acid oxidation (GO:0046320) | 2.84164649 |
57 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81990232 |
58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.81941492 |
59 | L-phenylalanine metabolic process (GO:0006558) | 2.81941492 |
60 | stress fiber assembly (GO:0043149) | 2.81906221 |
61 | 4-hydroxyproline metabolic process (GO:0019471) | 2.81350175 |
62 | protein localization to endosome (GO:0036010) | 2.80627722 |
63 | glutamate metabolic process (GO:0006536) | 2.80347040 |
64 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.79182971 |
65 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.78909408 |
66 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.78568080 |
67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.77410498 |
68 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.76134684 |
69 | protein targeting to plasma membrane (GO:0072661) | 2.75664423 |
70 | alanine transport (GO:0032328) | 2.74076741 |
71 | regulation of extracellular matrix disassembly (GO:0010715) | 2.74027922 |
72 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.73989602 |
73 | positive regulation of nuclease activity (GO:0032075) | 2.73959121 |
74 | layer formation in cerebral cortex (GO:0021819) | 2.73466361 |
75 | activation of protein kinase A activity (GO:0034199) | 2.73231822 |
76 | proline biosynthetic process (GO:0006561) | 2.72972257 |
77 | maternal placenta development (GO:0001893) | 2.70321492 |
78 | glyoxylate metabolic process (GO:0046487) | 2.70179392 |
79 | desmosome organization (GO:0002934) | 2.69502605 |
80 | cerebellar Purkinje cell layer development (GO:0021680) | 2.69254420 |
81 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.68449158 |
82 | cellular sodium ion homeostasis (GO:0006883) | 2.68183013 |
83 | cell-cell junction maintenance (GO:0045217) | 2.65312922 |
84 | amino-acid betaine metabolic process (GO:0006577) | 2.63819455 |
85 | positive regulation of receptor recycling (GO:0001921) | 2.63124851 |
86 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.62767056 |
87 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.61883341 |
88 | activation of MAPKKK activity (GO:0000185) | 2.61856879 |
89 | positive regulation of fatty acid oxidation (GO:0046321) | 2.61371408 |
90 | negative regulation of sterol transport (GO:0032372) | 2.61048457 |
91 | negative regulation of cholesterol transport (GO:0032375) | 2.61048457 |
92 | adhesion of symbiont to host (GO:0044406) | 2.60620245 |
93 | negative regulation of fatty acid transport (GO:2000192) | 2.60047326 |
94 | cell communication involved in cardiac conduction (GO:0086065) | 2.59138732 |
95 | response to mercury ion (GO:0046689) | 2.58884475 |
96 | protein retention in ER lumen (GO:0006621) | 2.58784375 |
97 | response to laminar fluid shear stress (GO:0034616) | 2.57740434 |
98 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.57571606 |
99 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.55952469 |
100 | positive regulation of protein dephosphorylation (GO:0035307) | 2.55475588 |
101 | negative regulation of lipid transport (GO:0032369) | 2.55322158 |
102 | urate metabolic process (GO:0046415) | 2.54333904 |
103 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.54235397 |
104 | regulation of translational termination (GO:0006449) | 2.54168979 |
105 | valine metabolic process (GO:0006573) | 2.54113385 |
106 | positive regulation of histone deacetylation (GO:0031065) | 2.52921306 |
107 | epithelial cell-cell adhesion (GO:0090136) | 2.52883852 |
108 | pinocytosis (GO:0006907) | 2.52225419 |
109 | NADH metabolic process (GO:0006734) | 2.51784904 |
110 | negative regulation of fibrinolysis (GO:0051918) | 2.51052953 |
111 | serine family amino acid catabolic process (GO:0009071) | 2.50510044 |
112 | amyloid precursor protein catabolic process (GO:0042987) | 2.49984412 |
113 | locomotory exploration behavior (GO:0035641) | 2.49915553 |
114 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49476031 |
115 | L-serine transport (GO:0015825) | 2.47821498 |
116 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.47472971 |
117 | NADPH regeneration (GO:0006740) | 2.47261309 |
118 | serine transport (GO:0032329) | 2.47103435 |
119 | homocysteine metabolic process (GO:0050667) | 2.46774748 |
120 | embryonic process involved in female pregnancy (GO:0060136) | 2.44840517 |
121 | modulation by virus of host morphology or physiology (GO:0019048) | 2.44442972 |
122 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.43832792 |
123 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.43802230 |
124 | ER-nucleus signaling pathway (GO:0006984) | 2.43581540 |
125 | fatty acid homeostasis (GO:0055089) | 2.43454233 |
126 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.43151085 |
127 | cellular ketone body metabolic process (GO:0046950) | 2.43047190 |
128 | mannose metabolic process (GO:0006013) | 2.43036949 |
129 | positive regulation of extracellular matrix organization (GO:1903055) | 2.42580625 |
130 | potassium ion import (GO:0010107) | 2.42511126 |
131 | regulation of nuclease activity (GO:0032069) | 2.42498362 |
132 | regulation of ARF protein signal transduction (GO:0032012) | 2.42381513 |
133 | modulation by symbiont of host cellular process (GO:0044068) | 2.42293969 |
134 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.42105369 |
135 | L-phenylalanine catabolic process (GO:0006559) | 2.42105369 |
136 | drug transmembrane transport (GO:0006855) | 2.42023385 |
137 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.39078368 |
138 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.38732607 |
139 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.38094945 |
140 | cell adhesion mediated by integrin (GO:0033627) | 2.37332103 |
141 | kynurenine metabolic process (GO:0070189) | 2.37268616 |
142 | drug catabolic process (GO:0042737) | 2.36949098 |
143 | peptidyl-proline hydroxylation (GO:0019511) | 2.36446664 |
144 | serine family amino acid metabolic process (GO:0009069) | 2.36064066 |
145 | urea metabolic process (GO:0019627) | 2.35658718 |
146 | urea cycle (GO:0000050) | 2.35658718 |
147 | acetyl-CoA metabolic process (GO:0006084) | 2.34913391 |
148 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.34123412 |
149 | cortical actin cytoskeleton organization (GO:0030866) | 2.34047720 |
150 | regulation of p38MAPK cascade (GO:1900744) | 2.33667188 |
151 | tricarboxylic acid cycle (GO:0006099) | 2.33526532 |
152 | regulation of defense response to virus by virus (GO:0050690) | 2.32949661 |
153 | actin filament bundle organization (GO:0061572) | 2.32786013 |
154 | actin filament bundle assembly (GO:0051017) | 2.32786013 |
155 | vesicle coating (GO:0006901) | 2.32713729 |
156 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.32485203 |
157 | membrane protein ectodomain proteolysis (GO:0006509) | 2.32243636 |
158 | cellular response to unfolded protein (GO:0034620) | 2.32050673 |
159 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.31690280 |
160 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.31416059 |
161 | hyaluronan catabolic process (GO:0030214) | 2.31300021 |
162 | glucose catabolic process (GO:0006007) | 2.31298708 |
163 | actin filament depolymerization (GO:0030042) | 2.31194164 |
164 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.30152197 |
165 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.28418355 |
166 | endothelial cell chemotaxis (GO:0035767) | 2.25796029 |
167 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.24705330 |
168 | cell volume homeostasis (GO:0006884) | 2.24401947 |
169 | virion attachment to host cell (GO:0019062) | 2.22158641 |
170 | adhesion of symbiont to host cell (GO:0044650) | 2.22158641 |
171 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.21808446 |
172 | embryo implantation (GO:0007566) | 2.20763835 |
173 | regulation of extracellular matrix organization (GO:1903053) | 2.16052597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.18933106 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.72208748 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99033645 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.98448295 |
5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.94551881 |
6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.56190279 |
7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.52717062 |
8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27911805 |
9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.25058167 |
10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24551233 |
11 | MYC_22102868_ChIP-Seq_BL_Human | 2.19408215 |
12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.19321296 |
13 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.13019966 |
14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.07198020 |
15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.06610073 |
16 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.99021597 |
17 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.98658577 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.98193631 |
19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88411077 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87358338 |
21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83362329 |
22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80637689 |
23 | KDM2B_26808549_Chip-Seq_K562_Human | 1.77290808 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76160078 |
25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73343594 |
26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71730754 |
27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67987750 |
28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.66392270 |
29 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.65735528 |
30 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.65010274 |
31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.63578475 |
32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63364658 |
33 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.61621793 |
34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61278656 |
35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58801531 |
36 | P68_20966046_ChIP-Seq_HELA_Human | 1.57650896 |
37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57161032 |
38 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.55601254 |
39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50385882 |
40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.49586620 |
41 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48763957 |
42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47331587 |
43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44382508 |
44 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42663037 |
45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41451317 |
46 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40815125 |
47 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.39310867 |
48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37752332 |
49 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.34451192 |
50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33453711 |
51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32061721 |
52 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32022577 |
53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31631695 |
54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31551911 |
55 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31212704 |
56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29906402 |
57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29494195 |
58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26569031 |
59 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25607855 |
60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25540842 |
61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24960694 |
62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24210317 |
63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23787386 |
64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23538874 |
65 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23233509 |
66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22389453 |
67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22337897 |
68 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.22168319 |
69 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21770518 |
70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20386753 |
71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18282655 |
72 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.17865390 |
73 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17702477 |
74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17331694 |
75 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.17252132 |
76 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15577996 |
77 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13571676 |
78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13357571 |
79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13206310 |
80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12550573 |
81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11434676 |
82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10438556 |
83 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10297388 |
84 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.10232602 |
85 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.09893982 |
86 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09750815 |
87 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09675719 |
88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09155667 |
89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09147020 |
90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08868135 |
91 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.08775566 |
92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08105666 |
93 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07993433 |
94 | MAF_26560356_Chip-Seq_TH1_Human | 1.07850997 |
95 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07799107 |
96 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07799107 |
97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07579669 |
98 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07444075 |
99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07001093 |
100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06354575 |
101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06118901 |
102 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05261236 |
103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04734184 |
104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04373410 |
105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03683835 |
106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03642753 |
107 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03173903 |
108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03126638 |
109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02963186 |
110 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02593117 |
111 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02310881 |
112 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01467246 |
113 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01318571 |
114 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.01203734 |
115 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00510247 |
116 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00375084 |
117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99831702 |
118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99667563 |
119 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99213000 |
120 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99155742 |
121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98962146 |
122 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98602945 |
123 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97815342 |
124 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96750223 |
125 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.95970674 |
126 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95580870 |
127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95554154 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.07624651 |
2 | MP0003705_abnormal_hypodermis_morpholog | 3.82542302 |
3 | MP0009840_abnormal_foam_cell | 3.76309133 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.31220143 |
5 | MP0005451_abnormal_body_composition | 3.25714806 |
6 | MP0003300_gastrointestinal_ulcer | 2.84028955 |
7 | MP0010234_abnormal_vibrissa_follicle | 2.78379016 |
8 | MP0008260_abnormal_autophagy | 2.50633330 |
9 | MP0002877_abnormal_melanocyte_morpholog | 2.38599222 |
10 | MP0003303_peritoneal_inflammation | 2.30600883 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.30181361 |
12 | MP0003329_amyloid_beta_deposits | 2.27524975 |
13 | MP0005365_abnormal_bile_salt | 2.26305228 |
14 | MP0005058_abnormal_lysosome_morphology | 2.24150155 |
15 | MP0005085_abnormal_gallbladder_physiolo | 2.19630142 |
16 | MP0008961_abnormal_basal_metabolism | 2.09708517 |
17 | MP0005257_abnormal_intraocular_pressure | 2.07655888 |
18 | MP0004859_abnormal_synaptic_plasticity | 2.05742288 |
19 | MP0003283_abnormal_digestive_organ | 2.04296627 |
20 | MP0010329_abnormal_lipoprotein_level | 1.96474918 |
21 | MP0002796_impaired_skin_barrier | 1.95064257 |
22 | MP0003252_abnormal_bile_duct | 1.90709482 |
23 | MP0004858_abnormal_nervous_system | 1.88751736 |
24 | MP0003453_abnormal_keratinocyte_physiol | 1.88694303 |
25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88488820 |
26 | MP0002909_abnormal_adrenal_gland | 1.86670285 |
27 | MP0005409_darkened_coat_color | 1.84222789 |
28 | MP0000604_amyloidosis | 1.80573300 |
29 | MP0005332_abnormal_amino_acid | 1.79047420 |
30 | MP0004130_abnormal_muscle_cell | 1.75411822 |
31 | MP0003279_aneurysm | 1.74818368 |
32 | MP0003172_abnormal_lysosome_physiology | 1.74128125 |
33 | MP0005167_abnormal_blood-brain_barrier | 1.72922462 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.66178150 |
35 | MP0002822_catalepsy | 1.62856626 |
36 | MP0005076_abnormal_cell_differentiation | 1.62675475 |
37 | MP0003566_abnormal_cell_adhesion | 1.62604541 |
38 | MP0000678_abnormal_parathyroid_gland | 1.57699523 |
39 | MP0005083_abnormal_biliary_tract | 1.55416038 |
40 | MP0010352_gastrointestinal_tract_polyps | 1.54180658 |
41 | MP0004185_abnormal_adipocyte_glucose | 1.53923503 |
42 | MP0009643_abnormal_urine_homeostasis | 1.53760135 |
43 | MP0001348_abnormal_lacrimal_gland | 1.53356057 |
44 | MP0004019_abnormal_vitamin_homeostasis | 1.49974415 |
45 | MP0005666_abnormal_adipose_tissue | 1.45956961 |
46 | MP0001666_abnormal_nutrient_absorption | 1.45526664 |
47 | MP0000013_abnormal_adipose_tissue | 1.43167651 |
48 | MP0003436_decreased_susceptibility_to | 1.43110210 |
49 | MP0000858_altered_metastatic_potential | 1.41394684 |
50 | MP0002060_abnormal_skin_morphology | 1.41335992 |
51 | MP0000609_abnormal_liver_physiology | 1.39889039 |
52 | MP0005501_abnormal_skin_physiology | 1.36568315 |
53 | MP0000747_muscle_weakness | 1.32410106 |
54 | MP0002118_abnormal_lipid_homeostasis | 1.31073272 |
55 | MP0001756_abnormal_urination | 1.28331462 |
56 | MP0002269_muscular_atrophy | 1.27698343 |
57 | MP0000751_myopathy | 1.27277332 |
58 | MP0003075_altered_response_to | 1.26961808 |
59 | MP0005375_adipose_tissue_phenotype | 1.25587961 |
60 | MP0004084_abnormal_cardiac_muscle | 1.24860377 |
61 | MP0009780_abnormal_chondrocyte_physiolo | 1.24273309 |
62 | MP0002089_abnormal_postnatal_growth/wei | 1.22462756 |
63 | MP0004233_abnormal_muscle_weight | 1.20341212 |
64 | MP0003634_abnormal_glial_cell | 1.20003573 |
65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19534934 |
66 | MP0000003_abnormal_adipose_tissue | 1.16914216 |
67 | MP0005319_abnormal_enzyme/_coenzyme | 1.12042016 |
68 | MP0005670_abnormal_white_adipose | 1.11245108 |
69 | MP0004087_abnormal_muscle_fiber | 1.10349236 |
70 | MP0001958_emphysema | 1.07851694 |
71 | MP0001849_ear_inflammation | 1.07715347 |
72 | MP0000920_abnormal_myelination | 1.06269699 |
73 | MP0005275_abnormal_skin_tensile | 1.05249559 |
74 | MP0001765_abnormal_ion_homeostasis | 1.04822311 |
75 | MP0005330_cardiomyopathy | 1.04545222 |
76 | MP0005377_hearing/vestibular/ear_phenot | 1.04522892 |
77 | MP0003878_abnormal_ear_physiology | 1.04522892 |
78 | MP0003879_abnormal_hair_cell | 1.02894334 |
79 | MP0002998_abnormal_bone_remodeling | 1.02675951 |
80 | MP0000767_abnormal_smooth_muscle | 1.01515531 |
81 | MP0010368_abnormal_lymphatic_system | 0.98123424 |
82 | MP0000579_abnormal_nail_morphology | 0.97812371 |
83 | MP0002653_abnormal_ependyma_morphology | 0.97748584 |
84 | MP0000467_abnormal_esophagus_morphology | 0.97683621 |
85 | MP0002249_abnormal_larynx_morphology | 0.97316495 |
86 | MP0004264_abnormal_extraembryonic_tissu | 0.97045952 |
87 | MP0000759_abnormal_skeletal_muscle | 0.95203286 |
88 | MP0003091_abnormal_cell_migration | 0.92873647 |
89 | MP0001533_abnormal_skeleton_physiology | 0.92741805 |
90 | MP0005023_abnormal_wound_healing | 0.92267901 |
91 | MP0005623_abnormal_meninges_morphology | 0.91696034 |
92 | MP0004043_abnormal_pH_regulation | 0.91485828 |
93 | MP0001915_intracranial_hemorrhage | 0.91346899 |
94 | MP0001216_abnormal_epidermal_layer | 0.90424536 |
95 | MP0005621_abnormal_cell_physiology | 0.90312564 |
96 | MP0004885_abnormal_endolymph | 0.89772007 |
97 | MP0002837_dystrophic_cardiac_calcinosis | 0.89751674 |
98 | MP0008438_abnormal_cutaneous_collagen | 0.89510680 |
99 | MP0009672_abnormal_birth_weight | 0.88214832 |
100 | MP0008874_decreased_physiological_sensi | 0.87027096 |
101 | MP0002136_abnormal_kidney_physiology | 0.85161690 |
102 | MP0005165_increased_susceptibility_to | 0.85053699 |
103 | MP0000598_abnormal_liver_morphology | 0.84077159 |
104 | MP0004782_abnormal_surfactant_physiolog | 0.82875741 |
105 | MP0003646_muscle_fatigue | 0.82326254 |
106 | MP0003183_abnormal_peptide_metabolism | 0.81605540 |
107 | MP0002254_reproductive_system_inflammat | 0.80358649 |
108 | MP0000750_abnormal_muscle_regeneration | 0.79712776 |
109 | MP0000681_abnormal_thyroid_gland | 0.79050982 |
110 | MP0004510_myositis | 0.78849082 |
111 | MP0005166_decreased_susceptibility_to | 0.78650990 |
112 | MP0010630_abnormal_cardiac_muscle | 0.77776114 |
113 | MP0006138_congestive_heart_failure | 0.77707749 |
114 | MP0003448_altered_tumor_morphology | 0.76773090 |
115 | MP0003656_abnormal_erythrocyte_physiolo | 0.75578198 |
116 | MP0003045_fibrosis | 0.75471804 |
117 | MP0000462_abnormal_digestive_system | 0.75238464 |
118 | MP0005508_abnormal_skeleton_morphology | 0.74613789 |
119 | MP0002971_abnormal_brown_adipose | 0.74561331 |
120 | MP0005390_skeleton_phenotype | 0.72893505 |
121 | MP0002078_abnormal_glucose_homeostasis | 0.72364882 |
122 | MP0003195_calcinosis | 0.72231930 |
123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71587492 |
124 | MP0004215_abnormal_myocardial_fiber | 0.71014055 |
125 | MP0000343_altered_response_to | 0.70651620 |
126 | MP0009333_abnormal_splenocyte_physiolog | 0.69217670 |
127 | MP0009931_abnormal_skin_appearance | 0.69020324 |
128 | MP0009384_cardiac_valve_regurgitation | 0.68531490 |
129 | MP0000537_abnormal_urethra_morphology | 0.68170267 |
130 | MP0003690_abnormal_glial_cell | 0.68090084 |
131 | MP0003806_abnormal_nucleotide_metabolis | 0.67688921 |
132 | MP0009053_abnormal_anal_canal | 0.66724202 |
133 | MP0009278_abnormal_bone_marrow | 0.66580434 |
134 | MP0002234_abnormal_pharynx_morphology | 0.66538610 |
135 | MP0005636_abnormal_mineral_homeostasis | 0.66513832 |
136 | MP0004036_abnormal_muscle_relaxation | 0.66386720 |
137 | MP0002970_abnormal_white_adipose | 0.65759883 |
138 | MP0002090_abnormal_vision | 0.65160441 |
139 | MP0004947_skin_inflammation | 0.64921237 |
140 | MP0010771_integument_phenotype | 0.64894928 |
141 | MP0001243_abnormal_dermal_layer | 0.64287018 |
142 | MP0000733_abnormal_muscle_development | 0.61538458 |
143 | MP0001542_abnormal_bone_strength | 0.61434211 |
144 | MP0008775_abnormal_heart_ventricle | 0.61418997 |
145 | MP0000534_abnormal_ureter_morphology | 0.61028752 |
146 | MP0002896_abnormal_bone_mineralization | 0.60669650 |
147 | MP0004272_abnormal_basement_membrane | 0.60292393 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vertebral compression fractures (HP:0002953) | 3.42989279 |
2 | Gout (HP:0001997) | 3.24935040 |
3 | Xanthomatosis (HP:0000991) | 3.19703881 |
4 | Cerebral aneurysm (HP:0004944) | 3.09965404 |
5 | Deep venous thrombosis (HP:0002625) | 3.03902821 |
6 | Abnormality of the Achilles tendon (HP:0005109) | 3.01753064 |
7 | Distal upper limb amyotrophy (HP:0007149) | 2.93870933 |
8 | Upper limb amyotrophy (HP:0009129) | 2.93870933 |
9 | Achilles tendon contracture (HP:0001771) | 2.90425741 |
10 | Neurofibrillary tangles (HP:0002185) | 2.83728527 |
11 | Polycythemia (HP:0001901) | 2.76818807 |
12 | Distal lower limb amyotrophy (HP:0008944) | 2.75175318 |
13 | Hand muscle atrophy (HP:0009130) | 2.74801639 |
14 | Distal lower limb muscle weakness (HP:0009053) | 2.66791375 |
15 | Obstructive sleep apnea (HP:0002870) | 2.60692884 |
16 | Dysostosis multiplex (HP:0000943) | 2.60363806 |
17 | Broad face (HP:0000283) | 2.57346373 |
18 | Hypoalphalipoproteinemia (HP:0003233) | 2.53959219 |
19 | Cervical subluxation (HP:0003308) | 2.53331468 |
20 | Abnormality of the lower motor neuron (HP:0002366) | 2.52178564 |
21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51716955 |
22 | Increased connective tissue (HP:0009025) | 2.49982599 |
23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.49531636 |
24 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.49531636 |
25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.49531636 |
26 | Protrusio acetabuli (HP:0003179) | 2.48231452 |
27 | Axonal loss (HP:0003447) | 2.46151659 |
28 | Ketosis (HP:0001946) | 2.44574351 |
29 | Ulnar bowing (HP:0003031) | 2.44167569 |
30 | Atrophic scars (HP:0001075) | 2.41172602 |
31 | Ketoacidosis (HP:0001993) | 2.37872469 |
32 | Spinal rigidity (HP:0003306) | 2.36833672 |
33 | Hyperammonemia (HP:0001987) | 2.36713969 |
34 | Mucopolysacchariduria (HP:0008155) | 2.34747923 |
35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34747923 |
36 | Fragile skin (HP:0001030) | 2.34195308 |
37 | Hyperacusis (HP:0010780) | 2.33367204 |
38 | Hyperglycinuria (HP:0003108) | 2.28477309 |
39 | Thin bony cortex (HP:0002753) | 2.27410379 |
40 | Lymphangioma (HP:0100764) | 2.26185658 |
41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.24841936 |
42 | Ventricular fibrillation (HP:0001663) | 2.21906450 |
43 | Hyperparathyroidism (HP:0000843) | 2.21384347 |
44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.20436264 |
45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.20436264 |
46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.20436264 |
47 | J-shaped sella turcica (HP:0002680) | 2.18724870 |
48 | Asymmetric septal hypertrophy (HP:0001670) | 2.18597511 |
49 | Back pain (HP:0003418) | 2.18396745 |
50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18100264 |
51 | Insomnia (HP:0100785) | 2.17934260 |
52 | Short nail (HP:0001799) | 2.17032862 |
53 | Complement deficiency (HP:0004431) | 2.16973509 |
54 | Global brain atrophy (HP:0002283) | 2.16236778 |
55 | Lower limb amyotrophy (HP:0007210) | 2.14579346 |
56 | Late onset (HP:0003584) | 2.12478452 |
57 | Difficulty climbing stairs (HP:0003551) | 2.12473825 |
58 | Ankle contracture (HP:0006466) | 2.11755531 |
59 | Aneurysm (HP:0002617) | 2.08149010 |
60 | Abnormality of glycine metabolism (HP:0010895) | 2.07591590 |
61 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.07591590 |
62 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.06763679 |
63 | Hyperlipoproteinemia (HP:0010980) | 2.06591377 |
64 | Bundle branch block (HP:0011710) | 2.05994467 |
65 | Hypoglycemic coma (HP:0001325) | 2.05508029 |
66 | Hypercortisolism (HP:0001578) | 2.04834345 |
67 | Right ventricular cardiomyopathy (HP:0011663) | 2.04795626 |
68 | Increased cerebral lipofuscin (HP:0011813) | 2.04045772 |
69 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.04020910 |
70 | Hemorrhage of the eye (HP:0011885) | 2.04015723 |
71 | Sensorimotor neuropathy (HP:0007141) | 2.03701948 |
72 | Nuclear cataract (HP:0100018) | 2.03596192 |
73 | Abnormality of purine metabolism (HP:0004352) | 2.03477476 |
74 | Hyperuricemia (HP:0002149) | 2.02366710 |
75 | Increased purine levels (HP:0004368) | 2.02366710 |
76 | Neonatal onset (HP:0003623) | 2.02188961 |
77 | Wormian bones (HP:0002645) | 1.99304112 |
78 | Hydroxyprolinuria (HP:0003080) | 1.99234388 |
79 | Abnormality of proline metabolism (HP:0010907) | 1.99234388 |
80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.98980307 |
81 | Turricephaly (HP:0000262) | 1.98690182 |
82 | Vascular tortuosity (HP:0004948) | 1.97250530 |
83 | Mitral regurgitation (HP:0001653) | 1.96681304 |
84 | Shallow orbits (HP:0000586) | 1.96664717 |
85 | Esophageal varix (HP:0002040) | 1.96278146 |
86 | Loss of speech (HP:0002371) | 1.94689554 |
87 | Blue sclerae (HP:0000592) | 1.94334851 |
88 | Long palpebral fissure (HP:0000637) | 1.93155812 |
89 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.92103943 |
90 | Myoglobinuria (HP:0002913) | 1.92002363 |
91 | Disproportionate tall stature (HP:0001519) | 1.91981732 |
92 | Arterial tortuosity (HP:0005116) | 1.91951179 |
93 | Polygenic inheritance (HP:0010982) | 1.91667849 |
94 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90657504 |
95 | Long toe (HP:0010511) | 1.90553098 |
96 | Abnormal gallbladder physiology (HP:0012438) | 1.89688581 |
97 | Cholecystitis (HP:0001082) | 1.89688581 |
98 | Systemic lupus erythematosus (HP:0002725) | 1.89144845 |
99 | Premature rupture of membranes (HP:0001788) | 1.88647040 |
100 | Enlarged penis (HP:0000040) | 1.88573332 |
101 | Spastic diplegia (HP:0001264) | 1.88215697 |
102 | Genu recurvatum (HP:0002816) | 1.87878505 |
103 | Neuronal loss in central nervous system (HP:0002529) | 1.87504895 |
104 | Stridor (HP:0010307) | 1.86914437 |
105 | Hypolipoproteinemia (HP:0010981) | 1.86653955 |
106 | Elfin facies (HP:0004428) | 1.86405005 |
107 | Generalized amyotrophy (HP:0003700) | 1.83364993 |
108 | Bladder diverticulum (HP:0000015) | 1.81851816 |
109 | Sudden death (HP:0001699) | 1.81110790 |
110 | Intrahepatic cholestasis (HP:0001406) | 1.79134634 |
111 | Hemiplegia (HP:0002301) | 1.78824822 |
112 | Atrioventricular block (HP:0001678) | 1.78446685 |
113 | Mitral valve prolapse (HP:0001634) | 1.78196127 |
114 | Aortic aneurysm (HP:0004942) | 1.77032275 |
115 | Elbow flexion contracture (HP:0002987) | 1.76964445 |
116 | Cerebral inclusion bodies (HP:0100314) | 1.76813602 |
117 | Biconcave vertebral bodies (HP:0004586) | 1.76457772 |
118 | Myocardial infarction (HP:0001658) | 1.76339872 |
119 | Difficulty running (HP:0009046) | 1.75675138 |
120 | Visceral angiomatosis (HP:0100761) | 1.75345694 |
121 | Mitral stenosis (HP:0001718) | 1.74431078 |
122 | Supranuclear gaze palsy (HP:0000605) | 1.73898659 |
123 | Flat acetabular roof (HP:0003180) | 1.73802609 |
124 | Growth hormone excess (HP:0000845) | 1.73115864 |
125 | Myokymia (HP:0002411) | 1.72770703 |
126 | Osteolytic defects of the hand bones (HP:0009699) | 1.72718201 |
127 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.72718201 |
128 | Hyperglycinemia (HP:0002154) | 1.72191849 |
129 | Frequent falls (HP:0002359) | 1.72038176 |
130 | Abnormality of complement system (HP:0005339) | 1.71249851 |
131 | Skin nodule (HP:0200036) | 1.71175429 |
132 | Athetosis (HP:0002305) | 1.71158704 |
133 | Limb-girdle muscle atrophy (HP:0003797) | 1.71105019 |
134 | Broad metatarsal (HP:0001783) | 1.70936972 |
135 | Advanced eruption of teeth (HP:0006288) | 1.70739926 |
136 | Malnutrition (HP:0004395) | 1.69448575 |
137 | Cardiomegaly (HP:0001640) | 1.69214027 |
138 | Striae distensae (HP:0001065) | 1.66747325 |
139 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.65369245 |
140 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.64832589 |
141 | Acanthosis nigricans (HP:0000956) | 1.64827042 |
142 | Pseudobulbar signs (HP:0002200) | 1.64672645 |
143 | Dysmetric saccades (HP:0000641) | 1.64465460 |
144 | Abnormality of carpal bone ossification (HP:0006257) | 1.64183668 |
145 | Bone pain (HP:0002653) | 1.63413322 |
146 | Hepatocellular carcinoma (HP:0001402) | 1.63209067 |
147 | Subacute progressive viral hepatitis (HP:0006572) | 1.62570420 |
148 | Abnormality of the thoracic spine (HP:0100711) | 1.62465782 |
149 | Status epilepticus (HP:0002133) | 1.62120354 |
150 | Natal tooth (HP:0000695) | 1.60975763 |
151 | Focal segmental glomerulosclerosis (HP:0000097) | 1.60526162 |
152 | Hemangiomatosis (HP:0007461) | 1.60286500 |
153 | Apathy (HP:0000741) | 1.60212820 |
154 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.59880025 |
155 | Dilatation of the ascending aorta (HP:0005111) | 1.59579669 |
156 | Coxa vara (HP:0002812) | 1.59420617 |
157 | Abnormal ossification of hand bones (HP:0005921) | 1.59213899 |
158 | Reticulocytosis (HP:0001923) | 1.58919344 |
159 | Myopathic facies (HP:0002058) | 1.58826047 |
160 | Amyloidosis (HP:0011034) | 1.58227018 |
161 | Postural instability (HP:0002172) | 1.57664183 |
162 | Distal sensory impairment (HP:0002936) | 1.57423499 |
163 | Increased circulating renin level (HP:0000848) | 1.56948299 |
164 | Interstitial pulmonary disease (HP:0006530) | 1.55995640 |
165 | Pointed chin (HP:0000307) | 1.55911464 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 5.07560137 |
2 | PKN2 | 3.51134617 |
3 | ERN1 | 3.21619904 |
4 | SMG1 | 2.87333446 |
5 | PRPF4B | 2.78423617 |
6 | KSR2 | 2.74972852 |
7 | IRAK3 | 2.70944849 |
8 | SCYL2 | 2.30377974 |
9 | RIPK1 | 2.27882672 |
10 | PRKD3 | 2.24832963 |
11 | MAP3K9 | 2.21415967 |
12 | ARAF | 2.06568093 |
13 | NEK1 | 2.03059980 |
14 | TAOK1 | 2.02058132 |
15 | LMTK2 | 1.93342280 |
16 | SIK1 | 1.85875698 |
17 | BCKDK | 1.81688030 |
18 | EEF2K | 1.81250589 |
19 | MAP3K10 | 1.77060417 |
20 | NME2 | 1.76130181 |
21 | PTK6 | 1.61749468 |
22 | PAK6 | 1.57859133 |
23 | TESK2 | 1.55546481 |
24 | CAMKK1 | 1.53217689 |
25 | TTN | 1.46377186 |
26 | KDR | 1.44884016 |
27 | PDGFRA | 1.29162237 |
28 | FGFR4 | 1.29118027 |
29 | MAP3K2 | 1.27628161 |
30 | ICK | 1.27547819 |
31 | DAPK2 | 1.23495748 |
32 | RET | 1.21544107 |
33 | MAP3K3 | 1.20646400 |
34 | MAP3K13 | 1.20405814 |
35 | TYRO3 | 1.19208150 |
36 | PAK4 | 1.18496884 |
37 | LRRK2 | 1.17610104 |
38 | MST1R | 1.16333211 |
39 | TESK1 | 1.15467816 |
40 | PIM2 | 1.14733573 |
41 | ALK | 1.11717456 |
42 | MARK2 | 1.09606118 |
43 | BMX | 1.08042159 |
44 | PTK2 | 1.07556294 |
45 | MAP3K11 | 1.06507036 |
46 | STK38 | 1.05629779 |
47 | NTRK1 | 1.04885682 |
48 | MOS | 0.97840652 |
49 | EPHA2 | 0.97742561 |
50 | PDK3 | 0.95301941 |
51 | PDK4 | 0.95301941 |
52 | CDC42BPA | 0.94201242 |
53 | LIMK1 | 0.91957859 |
54 | BRAF | 0.90962274 |
55 | DMPK | 0.88782718 |
56 | TBK1 | 0.88163437 |
57 | PDPK1 | 0.87277857 |
58 | CAMK1D | 0.86598131 |
59 | MINK1 | 0.84549677 |
60 | LATS2 | 0.82953583 |
61 | EPHB1 | 0.82900355 |
62 | MAP3K1 | 0.82193453 |
63 | MAP3K8 | 0.78962500 |
64 | WNK4 | 0.78535824 |
65 | PAK3 | 0.78317992 |
66 | MTOR | 0.76266771 |
67 | MAP2K1 | 0.75482513 |
68 | MAP2K2 | 0.74600470 |
69 | PRKCH | 0.74256220 |
70 | DAPK3 | 0.73801025 |
71 | FER | 0.71850069 |
72 | PDK1 | 0.69387926 |
73 | DYRK1B | 0.69237349 |
74 | KSR1 | 0.69136541 |
75 | MAP3K7 | 0.69050902 |
76 | PHKG2 | 0.67853780 |
77 | PHKG1 | 0.67853780 |
78 | SIK3 | 0.67231232 |
79 | JAK2 | 0.65297539 |
80 | CAMK1G | 0.65256090 |
81 | SIK2 | 0.63666286 |
82 | GRK6 | 0.62916117 |
83 | WNK3 | 0.62627290 |
84 | DDR2 | 0.61297038 |
85 | NEK2 | 0.60644873 |
86 | PAK2 | 0.60191792 |
87 | EPHA4 | 0.58954539 |
88 | RIPK4 | 0.58294143 |
89 | IRAK2 | 0.56353762 |
90 | TGFBR2 | 0.55945892 |
91 | PRKD1 | 0.54582287 |
92 | STK11 | 0.54132073 |
93 | JAK1 | 0.52022517 |
94 | MAP3K6 | 0.51170742 |
95 | ERBB2 | 0.51094266 |
96 | ABL2 | 0.49652626 |
97 | MAPK11 | 0.48854271 |
98 | FGFR1 | 0.47852101 |
99 | RPS6KL1 | 0.47655654 |
100 | RPS6KC1 | 0.47655654 |
101 | CAMK2G | 0.46993628 |
102 | MAP2K4 | 0.46752253 |
103 | TAOK3 | 0.46399910 |
104 | ILK | 0.46259623 |
105 | DAPK1 | 0.45827778 |
106 | CDK11A | 0.44996837 |
107 | ZAP70 | 0.43771081 |
108 | STK10 | 0.43674161 |
109 | MAP4K1 | 0.43257861 |
110 | MET | 0.43232382 |
111 | EPHB2 | 0.42739095 |
112 | HIPK2 | 0.42563526 |
113 | MAPK12 | 0.42552591 |
114 | PRKG2 | 0.40667247 |
115 | PRKCZ | 0.40272567 |
116 | CDK5 | 0.39629250 |
117 | TYK2 | 0.38728440 |
118 | CDK18 | 0.38623963 |
119 | PDK2 | 0.38547197 |
120 | MAPKAPK3 | 0.38378268 |
121 | TAOK2 | 0.38299024 |
122 | RAF1 | 0.38138503 |
123 | CDK14 | 0.37920577 |
124 | MAP2K3 | 0.37233857 |
125 | PRKAA1 | 0.36922875 |
126 | PRKD2 | 0.36312748 |
127 | CDK12 | 0.36165183 |
128 | ROCK1 | 0.35674420 |
129 | ROCK2 | 0.35494132 |
130 | AKT2 | 0.35151772 |
131 | CDK7 | 0.34864026 |
132 | CDK9 | 0.34236430 |
133 | CAMK2B | 0.33374088 |
134 | RPS6KA2 | 0.32960289 |
135 | CDK15 | 0.32675686 |
136 | SGK3 | 0.32551035 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.46638055 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07142657 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.53233777 |
4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.50231136 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18969658 |
6 | Bile secretion_Homo sapiens_hsa04976 | 2.07335760 |
7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.06517660 |
8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.02811880 |
9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.01646568 |
10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.99451381 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96516627 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90404144 |
13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.83088944 |
14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.69391784 |
15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57184576 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53906905 |
17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51257206 |
18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45530823 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45338330 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44509291 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43990945 |
22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43422762 |
23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.36357267 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32582199 |
25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26880401 |
26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26747350 |
27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24312175 |
28 | Amoebiasis_Homo sapiens_hsa05146 | 1.15976472 |
29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.13299193 |
30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12426926 |
31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05491538 |
32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05414232 |
33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02787697 |
34 | Bladder cancer_Homo sapiens_hsa05219 | 1.01825940 |
35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01760034 |
36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00805601 |
37 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00012649 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99427424 |
39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99038555 |
40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98221407 |
41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96863943 |
42 | Lysosome_Homo sapiens_hsa04142 | 0.96761445 |
43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93800804 |
44 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93575851 |
45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92141967 |
46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91447120 |
47 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91292414 |
48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89914374 |
49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89804399 |
50 | Insulin resistance_Homo sapiens_hsa04931 | 0.89373911 |
51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89032706 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 0.88316908 |
53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85928633 |
54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85903235 |
55 | Glioma_Homo sapiens_hsa05214 | 0.85669411 |
56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84595639 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84574057 |
58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83497288 |
59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82385475 |
60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82176143 |
61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81934450 |
62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81620340 |
63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81590425 |
64 | Hepatitis C_Homo sapiens_hsa05160 | 0.81564778 |
65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80584328 |
66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79721060 |
67 | Lysine degradation_Homo sapiens_hsa00310 | 0.78335204 |
68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77403615 |
69 | Shigellosis_Homo sapiens_hsa05131 | 0.77337033 |
70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77275416 |
71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74986344 |
72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74805397 |
73 | Prion diseases_Homo sapiens_hsa05020 | 0.74503144 |
74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74386343 |
75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73960037 |
76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73878502 |
77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73121568 |
78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.71596218 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71517258 |
80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70732064 |
81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70199794 |
82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70100146 |
83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69839631 |
84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69345955 |
85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69259195 |
86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68439716 |
87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68303491 |
88 | Adherens junction_Homo sapiens_hsa04520 | 0.67732319 |
89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67382697 |
90 | Apoptosis_Homo sapiens_hsa04210 | 0.67009763 |
91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66972390 |
92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66972363 |
93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66795044 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66724574 |
95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65929277 |
96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65540671 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.63821519 |
98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63330483 |
99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62878566 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62636863 |
101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62045175 |
102 | Pertussis_Homo sapiens_hsa05133 | 0.61322658 |
103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61085266 |
104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60702436 |
105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60238067 |
106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59635722 |
107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59520497 |
108 | Hepatitis B_Homo sapiens_hsa05161 | 0.59045286 |
109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58728060 |
110 | Mineral absorption_Homo sapiens_hsa04978 | 0.58343979 |
111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57758583 |
112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57601215 |
113 | Gap junction_Homo sapiens_hsa04540 | 0.57477957 |
114 | Salivary secretion_Homo sapiens_hsa04970 | 0.57079232 |
115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56976008 |
116 | Insulin secretion_Homo sapiens_hsa04911 | 0.56725841 |
117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56517190 |
118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56166651 |
119 | Prostate cancer_Homo sapiens_hsa05215 | 0.56155307 |
120 | Melanogenesis_Homo sapiens_hsa04916 | 0.55402522 |
121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54959842 |
122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53011024 |
123 | Focal adhesion_Homo sapiens_hsa04510 | 0.50461487 |
124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50170078 |
125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49029793 |
126 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48916205 |
127 | Tuberculosis_Homo sapiens_hsa05152 | 0.48587559 |
128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48473705 |
129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46551636 |
130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46410706 |
131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45004568 |
132 | ABC transporters_Homo sapiens_hsa02010 | 0.43613024 |
133 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41824392 |
134 | Peroxisome_Homo sapiens_hsa04146 | 0.41783326 |
135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41244134 |
136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41154835 |
137 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40061781 |
138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39153704 |
139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38507209 |
140 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38372353 |
141 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37951975 |